img

Global Tuberculosis (TB) Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Tuberculosis (TB) Treatment Market Research Report 2024

If you have latent tuberculosis, you may need to take only one or two types of TB drug. Active tuberculosis, particularly if it's a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide
According to MRAResearch’s new survey, global Tuberculosis (TB) Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tuberculosis (TB) Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Tuberculosis (TB) Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Johnson & Johnson
Otsuka Pharmaceutical Co., Ltd
Macleods Pharmaceutical Ltd
Dong-A ST Co., Ltd
Lupin Ltd
Janssen Products, LP
Mylan
Sanofi
Segment by Type
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide

Segment by Application


Active TB
Latent TB
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Tuberculosis (TB) Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Isoniazid
1.2.3 Rifampin (Rifadin, Rimactane)
1.2.4 Ethambutol (Myambutol)
1.2.5 Pyrazinamide
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Active TB
1.3.3 Latent TB
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis (TB) Treatment Market Perspective (2018-2033)
2.2 Tuberculosis (TB) Treatment Growth Trends by Region
2.2.1 Global Tuberculosis (TB) Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Tuberculosis (TB) Treatment Historic Market Size by Region (2018-2023)
2.2.3 Tuberculosis (TB) Treatment Forecasted Market Size by Region (2024-2033)
2.3 Tuberculosis (TB) Treatment Market Dynamics
2.3.1 Tuberculosis (TB) Treatment Industry Trends
2.3.2 Tuberculosis (TB) Treatment Market Drivers
2.3.3 Tuberculosis (TB) Treatment Market Challenges
2.3.4 Tuberculosis (TB) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis (TB) Treatment Players by Revenue
3.1.1 Global Top Tuberculosis (TB) Treatment Players by Revenue (2018-2023)
3.1.2 Global Tuberculosis (TB) Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Tuberculosis (TB) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis (TB) Treatment Revenue
3.4 Global Tuberculosis (TB) Treatment Market Concentration Ratio
3.4.1 Global Tuberculosis (TB) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Treatment Revenue in 2022
3.5 Tuberculosis (TB) Treatment Key Players Head office and Area Served
3.6 Key Players Tuberculosis (TB) Treatment Product Solution and Service
3.7 Date of Enter into Tuberculosis (TB) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis (TB) Treatment Breakdown Data by Type
4.1 Global Tuberculosis (TB) Treatment Historic Market Size by Type (2018-2023)
4.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2024-2033)
5 Tuberculosis (TB) Treatment Breakdown Data by Application
5.1 Global Tuberculosis (TB) Treatment Historic Market Size by Application (2018-2023)
5.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Tuberculosis (TB) Treatment Market Size (2018-2033)
6.2 North America Tuberculosis (TB) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Tuberculosis (TB) Treatment Market Size by Country (2018-2023)
6.4 North America Tuberculosis (TB) Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis (TB) Treatment Market Size (2018-2033)
7.2 Europe Tuberculosis (TB) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Tuberculosis (TB) Treatment Market Size by Country (2018-2023)
7.4 Europe Tuberculosis (TB) Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Treatment Market Size (2018-2033)
8.2 Asia-Pacific Tuberculosis (TB) Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tuberculosis (TB) Treatment Market Size (2018-2033)
9.2 Latin America Tuberculosis (TB) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Tuberculosis (TB) Treatment Market Size by Country (2018-2023)
9.4 Latin America Tuberculosis (TB) Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Treatment Market Size (2018-2033)
10.2 Middle East & Africa Tuberculosis (TB) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Tuberculosis (TB) Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.1.5 Johnson & Johnson Recent Development
11.2 Otsuka Pharmaceutical Co., Ltd
11.2.1 Otsuka Pharmaceutical Co., Ltd Company Detail
11.2.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.2.3 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Introduction
11.2.4 Otsuka Pharmaceutical Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.2.5 Otsuka Pharmaceutical Co., Ltd Recent Development
11.3 Macleods Pharmaceutical Ltd
11.3.1 Macleods Pharmaceutical Ltd Company Detail
11.3.2 Macleods Pharmaceutical Ltd Business Overview
11.3.3 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Introduction
11.3.4 Macleods Pharmaceutical Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.3.5 Macleods Pharmaceutical Ltd Recent Development
11.4 Dong-A ST Co., Ltd
11.4.1 Dong-A ST Co., Ltd Company Detail
11.4.2 Dong-A ST Co., Ltd Business Overview
11.4.3 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Introduction
11.4.4 Dong-A ST Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.4.5 Dong-A ST Co., Ltd Recent Development
11.5 Lupin Ltd
11.5.1 Lupin Ltd Company Detail
11.5.2 Lupin Ltd Business Overview
11.5.3 Lupin Ltd Tuberculosis (TB) Treatment Introduction
11.5.4 Lupin Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.5.5 Lupin Ltd Recent Development
11.6 Janssen Products, LP
11.6.1 Janssen Products, LP Company Detail
11.6.2 Janssen Products, LP Business Overview
11.6.3 Janssen Products, LP Tuberculosis (TB) Treatment Introduction
11.6.4 Janssen Products, LP Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.6.5 Janssen Products, LP Recent Development
11.7 Mylan
11.7.1 Mylan Company Detail
11.7.2 Mylan Business Overview
11.7.3 Mylan Tuberculosis (TB) Treatment Introduction
11.7.4 Mylan Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.7.5 Mylan Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Tuberculosis (TB) Treatment Introduction
11.8.4 Sanofi Revenue in Tuberculosis (TB) Treatment Business (2018-2023)
11.8.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Isoniazid
Table 3. Key Players of Rifampin (Rifadin, Rimactane)
Table 4. Key Players of Ethambutol (Myambutol)
Table 5. Key Players of Pyrazinamide
Table 6. Global Tuberculosis (TB) Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Tuberculosis (TB) Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Tuberculosis (TB) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Tuberculosis (TB) Treatment Market Share by Region (2018-2023)
Table 10. Global Tuberculosis (TB) Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Tuberculosis (TB) Treatment Market Share by Region (2024-2033)
Table 12. Tuberculosis (TB) Treatment Market Trends
Table 13. Tuberculosis (TB) Treatment Market Drivers
Table 14. Tuberculosis (TB) Treatment Market Challenges
Table 15. Tuberculosis (TB) Treatment Market Restraints
Table 16. Global Tuberculosis (TB) Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Tuberculosis (TB) Treatment Market Share by Players (2018-2023)
Table 18. Global Top Tuberculosis (TB) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Treatment as of 2022)
Table 19. Ranking of Global Top Tuberculosis (TB) Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Tuberculosis (TB) Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Tuberculosis (TB) Treatment Product Solution and Service
Table 23. Date of Enter into Tuberculosis (TB) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tuberculosis (TB) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Tuberculosis (TB) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Tuberculosis (TB) Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Tuberculosis (TB) Treatment Revenue Market Share by Application (2024-2033)
Table 33. North America Tuberculosis (TB) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Tuberculosis (TB) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Tuberculosis (TB) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Tuberculosis (TB) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Tuberculosis (TB) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Tuberculosis (TB) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Tuberculosis (TB) Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Tuberculosis (TB) Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Tuberculosis (TB) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Tuberculosis (TB) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Tuberculosis (TB) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Tuberculosis (TB) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Johnson & Johnson Company Detail
Table 49. Johnson & Johnson Business Overview
Table 50. Johnson & Johnson Tuberculosis (TB) Treatment Product
Table 51. Johnson & Johnson Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 52. Johnson & Johnson Recent Development
Table 53. Otsuka Pharmaceutical Co., Ltd Company Detail
Table 54. Otsuka Pharmaceutical Co., Ltd Business Overview
Table 55. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Product
Table 56. Otsuka Pharmaceutical Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 57. Otsuka Pharmaceutical Co., Ltd Recent Development
Table 58. Macleods Pharmaceutical Ltd Company Detail
Table 59. Macleods Pharmaceutical Ltd Business Overview
Table 60. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Product
Table 61. Macleods Pharmaceutical Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 62. Macleods Pharmaceutical Ltd Recent Development
Table 63. Dong-A ST Co., Ltd Company Detail
Table 64. Dong-A ST Co., Ltd Business Overview
Table 65. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Product
Table 66. Dong-A ST Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 67. Dong-A ST Co., Ltd Recent Development
Table 68. Lupin Ltd Company Detail
Table 69. Lupin Ltd Business Overview
Table 70. Lupin Ltd Tuberculosis (TB) Treatment Product
Table 71. Lupin Ltd Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 72. Lupin Ltd Recent Development
Table 73. Janssen Products, LP Company Detail
Table 74. Janssen Products, LP Business Overview
Table 75. Janssen Products, LP Tuberculosis (TB) Treatment Product
Table 76. Janssen Products, LP Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 77. Janssen Products, LP Recent Development
Table 78. Mylan Company Detail
Table 79. Mylan Business Overview
Table 80. Mylan Tuberculosis (TB) Treatment Product
Table 81. Mylan Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 82. Mylan Recent Development
Table 83. Sanofi Company Detail
Table 84. Sanofi Business Overview
Table 85. Sanofi Tuberculosis (TB) Treatment Product
Table 86. Sanofi Revenue in Tuberculosis (TB) Treatment Business (2018-2023) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis (TB) Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Tuberculosis (TB) Treatment Market Share by Type: 2022 VS 2033
Figure 3. Isoniazid Features
Figure 4. Rifampin (Rifadin, Rimactane) Features
Figure 5. Ethambutol (Myambutol) Features
Figure 6. Pyrazinamide Features
Figure 7. Global Tuberculosis (TB) Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Tuberculosis (TB) Treatment Market Share by Application: 2022 VS 2033
Figure 9. Active TB Case Studies
Figure 10. Latent TB Case Studies
Figure 11. Tuberculosis (TB) Treatment Report Years Considered
Figure 12. Global Tuberculosis (TB) Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Tuberculosis (TB) Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Tuberculosis (TB) Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Tuberculosis (TB) Treatment Market Share by Players in 2022
Figure 16. Global Top Tuberculosis (TB) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Treatment Revenue in 2022
Figure 18. North America Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Tuberculosis (TB) Treatment Market Share by Country (2018-2033)
Figure 20. United States Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Tuberculosis (TB) Treatment Market Share by Country (2018-2033)
Figure 24. Germany Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Tuberculosis (TB) Treatment Market Share by Region (2018-2033)
Figure 32. China Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Tuberculosis (TB) Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Tuberculosis (TB) Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Tuberculosis (TB) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Johnson & Johnson Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 47. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 48. Macleods Pharmaceutical Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 49. Dong-A ST Co., Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 50. Lupin Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 51. Janssen Products, LP Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 52. Mylan Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 53. Sanofi Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed